HCV - Hepatocellular Carcinoma

Metabolic Syndrome Is Associated with Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients
6/09/09

A Small Proportion of Hepatitis C Patients Develop Liver Cancer despite Sustained Response to Interferon-based Therapy
4/13/09

Long-term Maintenance Interferon Did Not Prevent Hepatocellular Carcinoma among Chronic Hepatitis C Patients in HALT-C Study
3/17/2009

U.S. Liver Cancer Rate Triples, but Survival Improves
3/13/2009

Open Phase 3 Study of Eltrombopag for Raising Platelet Levels in Patients with Chronic Liver Disease and Thrombocytopenia
2/27/09

Hepatitis C Virus May Persists at Low Levels after Sustained Response to Treatment; Liver Cancer May Develop Years Later
2/06/2009

Sustained Virological Response to Pegylated Interferon plus Ribavirin for Chronic Hepatitis C Does Not Always Prevent Hepatocellular Carcinoma
10/10/08

STORM Trial to Assess Sorafenib (Nexavar) as Adjuvant Therapy for Patients with Liver Cancer
9/12/2008

Hepatocellular Carcinoma Rates Vary Widely Across Sex and Racial/Ethnic Groups
7/25/08

Two Studies Look at Promising Therapies for Liver Cancer
7/25/08

Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C
7/04/08

Incidence of and Risk Factors for Hepatocellular Carcinoma in Hepatitis C Patients with Advanced Liver Disease: HALT-C Trial
5/16/08

Sorafenib (Nexavar) Improves Outcomes in Patients with Hepatocellular Carcinoma
5/16/08

Combination Therapy Improves Survival Time for Patients with Advanced Liver Cancer
4/11/08

Human Genetic Variation May Protect Against HCV-related Liver Disease Progression
1/04/08

Diabetes Is a Risk Factor for Liver Cancer Recurrence after Surgery in Patients with Viral Hepatitis
7/13/07

New Drug for Treatment of Liver Cancer
6/12/07